ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Title View Sessions
View by Date
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
  • A Bioinformatics Pipeline for the Identification of Crucial Factors for Transplant Rejection Based on NGS Data

    J. Vetter1, A. Heinzel2, C. Aschauer2, R. Reindl-Schwaighofer2, K. Jelencsics2, K. Hu2, R. Oberbauer2, S. Winkler1, S. Schaller1

  • A Call to Action: Finding the Right Kidney for All Potential Recipients

    G. Guerra, L. Preczewski, A. Harshman, G. Ciancio, R. Vianna, J. Figueiro, M. Muldoon

  • A Comparative Analysis of Mucormycosis in Solid Organ Transplant Recipients and Other Immunosuppressed Hosts Including Patients with Uncontrolled Diabetes

    T. Zangeneh1, J. Bardwell2, R. Bouzigard3, B. Youssefi2, C. Le4, M. Al-Obaidi2

  • A Comparison of Kidney Paired Donation Education Delivery Across 68 National Kidney Registry-Affiliated Centers

    A. Waterman1, E. H. Wood1, O. N. Ranasinghe1, J. L. Beaumont2, S. McGuire3, K. Miller4, V. Chipman5, J. Sinacore6, M. Cooper7

  • A Comparison of Temporal Gene Expression Patterns in Kidney, Heart, Liver, and Lung Transplant Biopsies

    P. Halloran1, J. Reeve1, .. the INTERLUNG Study Group2, .. the INTERHEART Study Group2, .. the INTERLIVER Study Group2, &. the INTERCOMEX Study Group2

  • A Comparison Study of Liver Regeneration in Laparoscopic versus Open Right Hemihepatectomy for Adult Living Donor Liver Transplantation

    J. Kim, J. Yang, J. Rhu, G. Choi, J. Joh

  • A Comprehensive Evaluation of Risk Factors for Pneumocystis Jiroveci Pneumonia in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis

    N. Permpalung1, V. Kittipibul2, P. Mekraksakit3, P. Rattanawong4, S. Nematollahi1, S. Mehta-Steinke1

  • A Data-Driven Approach to Defining the Volume-Outcome Relationship in Liver Transplantation

    M. D. Bailey, E. L. Godfrey, W. C. Frankel, A. Rana

  • A Data-Driven Approach to Defining the Volume-Outcome Relationship in Renal Transplantation

    E. L. Godfrey1, M. D. Bailey1, W. C. Frankel1, A. Rana2

  • A Follow-Up Over Time to the Impact of Reactive Anti-HCV and HCV NAT

    C. C. Muse, C. A. Hostetler, R. A. Squires, J. P. Orlowski

  • A Hybrid Data Envelopment Analysis-Artificial Neural Network (DEANN) Technique for Extrapolating the Evolution of Kidney Transplant Patients

    F. Santos-Arteaga1, D. Di Caprio2, D. Cucchiari3, J. M. Campistol3, F. Oppenheimer3, F. Diekmann3, I. Revuelta3

  • A Large Animal Model of Ex-Vivo Lung Perfusion as a Platform to Deliver Therapeutic Agents to Lungs Before Lung Transplant

    T. M. Egan1, B. Haithcock1, M. H. Ali1, J. W. Blackwell1, B. Masuodi1, S. Shipley2, T. Long3, A. Akerman1, S. Montgomery4, H. Yuan5, P. Stewart6, J. Potenziano7, C. Sekaran7, R. Fitch7

  • A Large Single Center Analysis of Medical and Surgical Complications Associated with Obesity after Kidney Transplantation in the Current Era

    F. Aziz, A. Ramadorai, S. Parajuli, N. Garg, M. Mohamed, D. Mandelbrot, D. Foley, M. Garren, A. Djamali

  • A Liver Transplant Candidate with Above Average Conscientiousness is More Likely to Receive a Liver Transplant

    O. Siddiqui1, J. Lai2, D. Peipert1, T. Kaundinya1, A. Daud1, A. Hall1, D. Ganger1, R. Wong2, C. Loftus1, D. Mroczek1, D. Ladner1

  • A Long-Term Follow-Up Study of High-Dose Intravenous Cyclosporine Combined Plasma Exchange in the Treatment of FSGS Recurrence after Renal Transplantation – A Single Center Clinical Experience

    Y. Cui, M. F. Wang, C. C. Wei, J. Y. Wu

  • A Machine-Learning Approach for Estimating Likelihood of Transplant Benefit from Older-Donor Kidneys

    T. Pruett1, P. Martin2, D. Gupta3

  • A Monocyte-Derived MicroRNA Signature for Antibody-Mediated Rejection in Kidney Transplantation

    C. Tinel1, B. Lamarthée1, F. Von Tokarski1, M. Rabant2, C. Legendre1, W. Gwinner3, M. Naesens4, P. Marquet5, D. Anglicheau1

  • A Mouse Model of Non-MHC Mismatches Recapitulates Chronic Allograft Dysfunction and I-IFTA

    V. Pavlov1, F. Garzon1, R. Haroon Al Rasheed2, K. Banu1, F. ElSalem1, L. Li1, E. Cody1, M. Planoutene1, N. Chun1, Z. Zhang1, J. Leventhal1, B. Murphy1, P. Heeger1, M. C. Menon1

  • A Mouse Model of Paratopic Intestinal Transplantation to Delineate GVHD-Free Alloimmune Rejection Responses

    A. Dangi1, J. Wang2, A. Joseph3, J. Roper3, N. Surana4, X. Luo1

  • A Multi-Center Pilot and Feasibility Randomized Clinical Trial of a Home-Based Exercise Program for Patients with Cirrhosis: The Strength Training Intervention

    J. C. Lai1, M. R. Kappus2, J. L. Dodge1, R. Wong1, Y. Mohamad1, D. L. Segev3, M. A. McAdams-DeMarco4

  • A Multicenter Analysis of the Proportion and Pattern of Unexplained HLA Antibodies in Kidney Recipients without a History of Sensitization

    J. Lan1, J. S. Gill1, H. M. Gebel2, R. A. Bray2, R. Liwski3, A. Vinson4, A. Greenshields3, S. Dobrer5, O. Gunther5, K. Sherwood5, F. H. Claas6, S. Heidt6, G. Karahan6, J. Gill7, M. Gill1, U. Varyani1, P. Jindal1, P. Keown5

  • A Multicenter, Randomized, Controlled Trial to Steer Immunosuppressive Therapy by Virus-Specific T Cells after Pediatric Kidney Transplantation (IVIST-Trial)

    T. Ahlenstiel-Grunow1, A. Großhennig1, R. Schild2, J. Oh2, C. Taylan3, L. Weber3, H. Staude4, M. Verboom1, C. Schröder1, R. Sabau1, A. Koch1, X. Liu1, L. Pape1

  • A Multidisciplinary Protocol for the Management of Hyponatremia at the Time of Liver Transplantation is Associated with Reduced Post-Transplant Neurologic Complications

    J. F. Crismale, T. Huisman, R. Deshpande, C. Law, G. Im, D. Bronster, S. Demaria Jr, S. Florman, T. Schiano

  • A NASHional Crisis: Liver Transplantation Outcomes in Female Hispanics

    R. A. Sosa1, A. Q. Terry1, M. Rossetti1, F. M. Kaldas2, B. V. Naini1, J. Nevarez-Mejia1, V. M. Groysberg1, S. Younan2, R. W. Busuttil2, D. W. Gjertson1, J. W. Kupiec-Weglinski2, E. F. Reed1

  • A New Diagnostic Approach to HLA Testing in Kidney Transplant Patients Using Renal Epithelial Cells

    M. Herrmann1, C. Bach2, K. X. Knaup1, M. Schiffer1, B. Spriewald2, M. S. Wiesener1

  • A Nonhuman Primate Model of Intestinal Transplantation – Technical Aspects and Early Outcomes

    R. Schmitz1, J. Yoon1, M. Song1, E. Jelly2, A. P. Wax2, S. J. Knechtle1, D. L. Sudan1, J. Kwun1

  • A Novel Formula to Determine Optimal Immunosuppression in Renal Transplant Recipients Treated with Tacrolimus and Mycophenolate Mofetil: Towards Individualized Immunosuppression

    O. Pankewycz1, M. Laftavi1, E. Onan2, D. Rucker1, D. Wang1, K. Bhuta1, R. Gruessner3, A. Gruessner3

  • A Novel Immunoresponse Monitoring System to Predict Chronic Antibody- Mediated Rejection in Kidney Transplant Recipients

    N. Iwahara1, K. Hotta1, D. Iwami1, Y. Takada1, H. Higuchi2, H. Sasaki2, T. Tanabe2, N. Shinohara1

  • A Novel Injectable Hydrogel-Based Approach to Localize and Tune the Actuation of Enhanced Costimulation Blockade to the Strength of Transplant Rejection

    A. Komin1, C. Liang2, P. Majumder2, X. Calderon-Colon3, O. Tiburzi3, M. Iglesias Lozano1, Y. Zhang1, G. Brandacher1, J. Patrone3, J. Schneider2, G. Raimondi1

  • A Novel Polymer Product, APP-103, Reduces IRI-Induced Damage and Promotes Functional Improvement in Syngeneic Models of Renal Transplantation

    K. Minami1, S. Bae2, H. Uehara1, J. Iske1, J. Reder3, H. Azuma4, A. Weins1, E. Van Keuren5, B. Houser3, A. El-Khal1, P. Kang2, S. Tullius1

  • A Pilot Study of Mkidney: A Novel Mobile Health Platform to Support OPTN Living Donor Follow-Up Data Collection

    C. Sidoti1, W. Zhang1, M. Waldram1, A. Thomas1, M. Levan1, A. Massie1, A. Bingaman2, R. Forbes3, G. Edwards3, K. Warmke3, K. Centanni3, D. Segev1, M. Henderson1

  • A Population-Based Analysis of Hepatocellular Carcinoma in Children: Identifying Optimal Surgical Treatment

    I. A. Ziogas1, L. K. Matsuoka1, M. I. Montenovo1, M. Izzy1, D. J. Benedetti1, H. N. Lovvorn III2, L. A. Gillis1, S. P. Alexopoulos1

  • A Proof-of-Principle Study to Evaluate Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance (ASCOTT)

    A. Chruscinski1, S. Juvet1, S. Moshkelgosha1, E. Renner1, L. Lilly1, N. Selzner1, C. Bredeson2, O. Adeyi1, S. Fischer1, A. Demetris3, J. Zhang1, M. Epstein1, A. Clement2, K. Khalili1, Z. Galvin1, A. Humar1, T. Kim1, K. Tinckham1, T. Yi1, G. Levy1, H. Atkins2

  • A Prospective Randomized Multicenter Trial (BEST Trial) of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression: Infectious Complications

    P. West-Thielke1, A. Shields2, D. Kaufman3, J. Leone4, A. Wiseman5, A. Matas6, T. Sa7, E. King7, R. Alloway2, S. Woodle2

  • A Quality Improvement Project to Reduce the Risk of Alcohol Relapse after Liver Transplantation by Implementing a High-Risk Alcoholism Relapse Scale

    R. V. Tholen1, E. Bundy2

  • A Recombinant, Fully Human ATG Polyclonal Antibody Drug Drives Immune Cell Depletion in a Model of Graft-versus-Host Disease

    S. M. Keating, A. S. Adler, R. A. Mizrahi, J. Leong, M. A. Asensio, Y. W. Lim, A. R. Niedecken, Y. Chiang, R. Leong, D. S. Johnson

  • A Simple HLA Class II Matching Strategy for the Prediction of De Novo Donor-Specific HLA Antibodies

    L. G. Hidalgo1, I. A. Martinez Juarez2, L. Morales-Buenrostro3, S. Shojai4, P. Campbell4

  • A Simple Scoring System for Risk Stratification in Liver Transplantation after Donor Liver Biopsy

    J. A. Steggerda, M. B. Bloom, K. Mahendraraj, T. Ramos, T. Todo, T. V. Brennan, N. N. Nissen, A. S. Klein, I. K. Kim

  • A Single Center Experience of Atypical Hemolytic Uremic Syndrome Post Solid Organ Transplantation – “Benign Genetic Variants: Perhaps No More”

    M. Khan, M. Anand, T. Kaur, S. Bumb, S. Shah, A. Govil, B. G. Abu Jawdeh

  • A Single Centre Experience of Conversion from Immediate Release Tacrolimus (IR-tac) to Extended Release Envarsus

    S. Chong1, E. Kent2, C. Beligaswatta2, P. Gudka2, C. Magee2, M. Harber2, R. Motallebzadeh1, G. Jones2

  • A Single Centre Report of Renal Transplantation Against a Positive Crossmatch Due to HLA-DP Donor Specific Antibodies without Prior Antibody Removal

    Y. Marie1, T. Key2, A. Halawa1

  • A Single Nucleotide Polymorphism of Tweak Predicts Arterio- and Arteriolohyalinosis in Kidney Transplants and is Associated with Allograft Survival

    A. Karolin1, D. Thottan1, J. Zinsli1, S. Rudloff1, U. Huynh-Do1, V. Banz2, T. Berney3, M. Pascual4, T. Müller5, P. d’Amico6, I. Binet7, D. Sidler1

  • A Single-Cell Transcriptome Atlas of 15 Adult Human Organs

    Z. Guo1, S. He2, L. Wang1, Y. Liu2, J. Xu1, J. Bei2, X. He1

  • A Single-Center Analysis of Using Allele-Level 11 HLA Loci Information on cPRA and Organ-Allocation Points in Kidney Transplant Candidates

    C. Maguire1, P. Muluhngwi1, E. Kransdorf2, L. Gragert3, A. R. Tambur1

  • A Single-Center Characterization of the Living Liver Donor Evaluation Process

    L. R. Herbst, A. D. Love, M. Krach, Y. Yu, L. Kurman, A. Gurakar, M. Hammami, A. M. Cameron, J. Garonzik Wang

  • A Single-Center Experience in Transfusion-Free Liver Transplantation: Referrals and Outcomes from 2005 to 2019

    B. H. Horwich1, A. Mulgaonkar1, B. Kim2, N. Kaur1, J. Kahn2, Y. Genyk3, A. Ahearn3, H. Han2

  • A Stroke Volume-Based Fluid Resuscitation Protocol Decreases Vasopressor Support and Increases Organ Yield in Brain-Dead Donors

    G. F. Marklin

  • A Successful Kidney Transplantation from Hepatitis C NAT Positive Deceased Donor to an HIV Positive Recipient with Previous History of Treated HCV Infection

    R. H. Naik, S. Shawar, H. Schaefer

  • A Survey of Lung Transplant Recipient Attitudes and Beliefs on Accepting an Organ That Was Positive for Hepatitis C Virus

    S. S. Humar1, N. Pinzon1, M. Cypel1, S. Abbey2

  • A Technique for Ex-Vivo Perfusion of Donor Kidneys for Transplantation in the Mouse

    R. Plenter1, S. Jain2, J. J. Pomposelli1, T. Nydam1, A. Jani2

  • A Three-Decade Analysis of Pancreatic Adenocarcinoma Following Liver Transplantation

    O. Y. Mousa1, J. E. Corral2, K. Wijarnpreecha2, R. Shah3, V. S. Louwagie4, M. J. Bartel5, B. Brahmbhatt2

  • A Two-Step Cell-Based Assay Predicts Immunosuppression-Related Adverse Events in Kidney Transplant Recipients

    F. Bouchard-Boivin, O. Désy, S. Béland, S. De Serres

  • A Video Education Intervention to Improve Kidney Transplant Knowledge and Self-Efficacy in Dialysis Center End Stage Renal Disease (ESRD) Patients

    D. A. DuBay1, T. Morinelli1, Z. Sutton1, M. Chastain1, T. Thompkins Tindal1, Z. Su1, E. Weeda1, P. Mauldin1, M. Casey1, J. Bian1, J. Rodrigue2, P. Baliga1, D. Taber3

  • A Video Education Intervention to Improve Kidney Transplant Knowledge and Willingness to Complete Transplant Evaluation in Dialysis Patients

    D. A. DuBay1, T. A. Morinelli1, Z. Sutton1, M. Chastain1, T. Thompkins Tindal1, Z. Su2, E. Weeda3, P. Mauldin4, M. Casey1, J. Bian2, D. Taber1, P. K. Baliga1

  • Abdominal Multiorgan Retrieval from Pigs in a Slaughterhouse: A Reliable and Efficient Donation after Circulatory Death Model for Ex Vivo Organ Perfusion

    F. Neri, F. Dengu, G. Ebeling, L. Knijff, K. Rozemberg, J. Branchereau, P. Friend, R. Ploeg, J. Hunter

  • ABH Subtype-Specific Tolerance after ABO-Mismatched Hematopoietic Cell Transplantation

    B. Motyka1, A. Halpin1, J. Pearcey1, A. Kariminia2, A. Halevy2, S. Maier1, A. Halevy2, P. Subrt2, C. W. Cairo1, G. D. Cuvelier3, K. R. Schultz2, L. J. West1

  • ABO Self-Tolerance in a Mouse Model: Evidence of Tolerance at B Cell but Not T Cell Level

    I. Adam, B. Motyka, K. Tao, L. West

  • Absence of Adverse Infectious Disease Outcomes in the Long-Term Follow-Up of Recipients of PHS Increased Risk Donor Organs: An Essential Tracking Program

    L. Irwin, J. Fishman

  • Absolute Lymphocyte Count: Is There a “Safety Corridor?”

    G. Elhelou1, B. Lahr2, R. Razonable3

  • Accelerated Bronchiolitis Obliterans after Lung Transplant Promoted by the ATG16L1 rs2241880 Mutation is Coupled to Mitochondrial Damage and Metabolic Alterations in Monocyte-Derived Alveolar Macrophages

    M. Cano1, D. Zhou2, D. Kreisel3, C. Chen4, K. Pugh2, D. Byers1, R. Hachem1, A. E. Gelman3

  • Accelerated Decline in Glomerular Density: An Unrecognized Pathologic Process after Kidney Transplantation

    A. Denic, B. H. Smith, W. D. Park, M. V. Luhman, M. P. Alexander, A. D. Rule, M. D. Stegall

  • Access to and Survival Benefit of Kidney Transplantation in Patients with Sickle Cell Disease-Associated End-Stage Renal Disease in the United States

    S. Bae, M. Johnson, A. Massie, X. Luo, C. Haywood Jr., S. Lanzkron, M. Grams, D. Segev, T. Purnell

  • Access to Direct Acting Antiviral Therapy for Recipients of Solid Organs from Hepatitis C Viremic Donors

    C. Edmonds, A. Carver, J. DeClercq, L. Choi, M. Peter, R. Forbes, B. Concepcion, K. Schlendorf, R. Perri

  • Accommodating Increasing Volumes without Knocking Down Walls: Update on an Infusion Center’s Growth

    J. C. Estrada

  • Accomplishment of Ischemia-Free Kidney Transplantation Using Normothermic Machine Perfusion

    G. Chen, X. He, C. Wang, X. Yuan, M. Han, Z. Guo

  • Accuracy Of Agitated Saline Contrast Echocardiography For Assessment Of Intracardiac Shunting In Preoperative Liver Transplant Patients

    B. B. Swanson1, R. Salgia2, J. El-Bashir3, S. Parikh1

  • Activated CD27+CD21– Subset Dominate the Memory B Cell Response During Antibody-Mediated Rejection of Kidney Allografts

    K. Louis1, E. Bailly1, C. Macedo1, M. Marrari1, M. Yamada1, P. Randhawa1, A. Zeevi1, C. Lefaucheur2, D. Metes1

  • Activated Circulating Memory T Follicular Helper Cells with Self-Renewal Potential Underlie the Kidney Allograft Antibody-Mediated Rejection Response

    K. Louis1, C. Macedo1, E. Bailly1, B. Ramaswami1, M. Marrari1, T. Shi1, D. Landsittel1, U. Chandran1, P. Fadakar1, M. Yamada1, G. Chalasani1, P. Randhawa1, A. Zeevi1, C. Lefaucheur2, D. Metes1

  • Activation of Tacrolimus Induced Cytotoxicity Through Apoptotic Pathways

    S. Chung, S. Choi

  • Activation of the ICOS/ICOS-Ligand Pathway in Antibody-Mediated Kidney Graft Rejection

    V. Cantaluppi1, G. Merlotti1, M. Quaglia1, G. Rosso1, N. Clemente1, G. Cappellano1, A. Chiocchetti1, G. Castellano2, U. Dianzani1, G. Camussi3

  • Activation of YAP Attenuates Hepatic Damage and Fibrosis in Liver Ischemia-Reperfusion Injury: From Bench to Bedside

    Y. Liu1, T. Lu2, C. Zhang1, Z. Xue1, R. Busuttil1, J. Kupiec-Weglinski1, H. Ji1

  • Active Vitamin D Prior to Transplant Affects Post-Transplant Outcomes

    L. Al Dahabreh1, C. Abou-Mitri1, L. Negrea1, K. Chavin2, T. Srinivas1, A. Padiyar1

  • Acute Kidney Injury And Chronic Kidney Disease After Lung Transplantation: Incidence And Risk Factors In A Large Single-center Cohort

    D. Abdelwahab, R. Marron, Z. Choudhry, I. Lee, J. Wu, J. Brown

  • Acute Kidney Injury in Deceased Organ Donors and Kidney Transplant Outcomes Using a Novel Data Source

    E. M. Sonnenberg, J. Hsu, J. Cohen, V. Potluri, M. H. Levine, P. L. Abt, P. P. Reese

  • Acute Liver Failure Etiology is an Independent Predictor of Waitlist Outcome Accounting for Severity of Illness in a National Cohort

    N. Z. Wong, K. R. Reddy, T. Bittermann

  • Acute Liver Failure Requiring Liver Transplantation Due to Acute Hepatitis A Infection: A Case Series

    C. Xie1, J. M. Fenkel1, D. L. Halegoua-DeMarzio1, J. M. Civan1, D. M. Tholey1, S. K. Herrine1, M. Thapar1, S. Arastu1, A. M. Frank2, A. P. Shah2, J. M. Glorioso2, C. G. Ramirez2, A. S. Bodzin2, W. R. Maley2, D. A. Sass1

  • Acute on Chronic Liver Failure (ACLF) Patients Have a Dynamic and Progressive Clinical Course Until Receiving a Liver Transplant: A 5-Year Study at the National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico

    E. Cervantes-Alvarez1, M. J. Lizardo-Thiebaud1, E. Alatorre-Arenas1, O. Mendez-Guerrero1, S. Yarza-Regalado1, A. Torre1, M. Vilatobá2, D. Kershenobich1, C. A. Huang3, N. Navarro-Alvarez1

  • Acute Portal Vein Thrombosis after Pediatric Living Donor Liver Transplantation: Re-Do Portal Vein Anastomosis vs Thrombectomy and Prophylactic Portal Vein Stenting Through Re-Opened Umbilical Vein- Breaching the Technical Barrier!

    A. Thorat, D. Mirza, V. Raut, K. Shah, A. Raj

  • Acute Rejection in Liver Transplant Recipients is a Rising Predictor of Death and Graft Failure in the Recent Era of Declining Hepatitis C Virus

    T. Bittermann1, D. S. Goldberg2, J. Levitsky3

  • Acute Rejection in the First Year is a Risk Factor for Subsequent Cardiac Events in Kidney Transplant Recipients

    F. Aziz, R. Tao, S. Parajuli, N. Garg, D. Mandelbrot, B. Astor, A. Djamali

  • Acute Respiratory Distress Syndrome in a Simultaneous Kidney/Pancreas Transplant Recipient after “Dabbing” with Marijuana Rosin: A Case Report

    M. Baska1, H. Kerr2, K. Eid2, K. Gabrys3, I. Khan4, M. Quraishi4, F. Barrantes3

  • Adaptive Induction Therapy in Renal Transplant Recipients (RTR) with Donor-Specific Antibody (DSA)

    K. Linhares1, M. Cristelli2, R. De Marco3, L. Viana2, C. Felipe2, M. Tavares2, C. Peixoto2, G. Marcello2, J. Toniato2, K. Ficher2, L. Villanueva2, L. Villanueva2, M. De Lima3, J. Pestana2, H. Tedesco Jr.2

  • Additive Effect of Obesity to Hypertension in Living Donors and Their Impact on Glomerular Filtration Rate Compensation with 5 Year Follow-Up

    S. Quadri1, H. Ali2, T. Fulop1, A. Osman3, K. Soliman1

  • Addressing Critiques of the Proposed CMS Metric of Organ Procurement Organ Performance: More Data Isn’t Better

    D. Goldberg1, B. Doby2, R. Lynch3

  • Adenovirus Infection in Kidney Transplant Recipients: A Case Series

    S. Anjan, Y. Natori, M. Raja, J. Camargo, J. Simkins, M. Morris, A. Fernandez, G. Ciancio, L. Chen, G. Burke, M. Ortigosa-Goggins, J. Pagan, A. Mattiazzi, G. Guerra, L. Abbo

  • Adenovirus Infection in Pediatric Liver Transplant Recipients: A Single Center Experience

    S. Hassan1, K. R. Mysore1, M. E. Faraone2, D. Cerminara3, K. Hosek4, E. Moulton5, C. Bocchini5, R. Sigereddi6, R. Ackah6, F. Muñoz5, A. Rana7, J. Goss7, D. H. Leung1, T. Galvan7

  • Adjuvant Immunotherapy for Liver Transplant Recipients with Hepatocellular Carcinoma Using Donor Liver Derived Natural Killer Cells

    M. Ohira1, R. Hotta1, Y. Imaoka1, K. Sato1, N. Tanimine1, H. Tahara1, K. Ide1, T. Kobayashi1, Y. Tanaka1, A. Tzakis2, S. Nishida2, H. Ohdan1

  • Adult Liver Transplant Recipients Show Increased Fibrinolysis Resistance Compared with Pediatric Recipients: The Potential Impact of Anticoagulation between the Two Populations

    H. B. Moore, T. Nydam, R. Choudhury, A. Schulick, C. Walker, M. Wachs, M. A. Adams

  • Adult Living Donor Liver Transplantation Results in Superior Patient and Graft Survival When Compared to Deceased Donor Liver Transplantation: A Systematic Review and Meta-Analysis

    A. Barbetta1, M. Aljehani2, M. KIM1, C. Tien3, A. Ahearn1, H. Schilperoort2, L. Sher1, J. Emamaullee1

  • Adult Primary Liver Transplant Recipient Outcomes by Immunosuppression Induction Received

    T. Shaker1, G. Larrieux1, S. Jackson2, S. Riad3, T. Pruett1, T. Leventhal4

  • Adult Split Liver Transplants Increased after Implementation of a Pediatric Liver Transplant Program

    J. Cullen1, P. Vargas1, S. Pelletier1, K. Soltys2, S. Rasmussen1, G. Mazariegos2, J. Oberholzer1, N. Goldaracena1

  • Affect in Patients Awaiting Heart Transplant

    A. Ahmed1, D. S. Yip2, B. W. Hardaway3, B. A. Boilson4, T. D. Schneekloth5, R. Benzo1, R. Daly6, M. A. Hathcock7, B. K. Johnson7, K. Thompson8, C. C. Kennedy9

  • African American Patient Perceptions of Live Kidney Donation and Educational Health Animations

    R. E. Seibert1, M. Keller2, B. Dolph3, T. H. Feeley4, L. K. Kayler3

  • Age Mismatch between Donor and Recipient in Heart Transplant and its Effect on Mortality

    A. Kumar1, L. Bonell2, M. Prikis1

  • Age- and Sex-Mediated Differences in T Lymphocyte Populations of Kidney Transplant Recipients

    R. Dziarmaga1, D. Ke1, V. Phan2, H. Cardinal3, R. Sapir-Pichhadze1, C. A. Piccirillo1, B. Mazer1, B. Foster1

  • Age-Enhanced Transplant Vasculopathy Associates with Impaired Vascular Mitophagy

    M. Blin1, D. Tyrrell1, S. Wood1, D. Farris1, S. G. Tullius2, D. R. Goldstein1

  • Aging Aggravated Liver Ischemia and Reperfusion Injury by Promoting Sting-Mediated NLRP3 Activation in Macrophages

    Z. Rao, W. Zhong, H. Zhou, P. Wang, X. Wang, L. Lu

  • Agonistic Anti-CD272 Antibody (6B2) Suppressed Donor Specific Antibody Through Inducible Regulatory T Cells

    Y. Yamamoto1, M. Uchiyama2, K. Uchida3, H. Yagita4, M. Niimi1

  • AIPCs Home to and Engraft in the Pancreas When Injected Intravenously

    J. B. Pollett1, N. Thai2

  • Alcohol Relapse after Liver Transplant for Alcohol-Related Cirrhosis: A Longitudinal Assessment of Risk Factors for Relapse and Long-Term Survival

    B. Rice, N. Mehta, J. L. Dodge, J. D. Grab, C. Sherman

  • Alemtuzumab and Associated Infectious and Transplant Outcomes in Renal Re-Transplant Patients

    T. N. Harris

  • Allograft Loss and Patient Death among Kidney Transplant Recipients; Is Therapy Non-Adherence the Underlying Perpetrator?

    K. Kalra, R. Munjal, A. Cherukuri, R. Mehta, C. Puttarajappa, D. Jorgensen, P. Sood, C. Wu, N. Shah, S. Hariharan

  • Allograft Parenchymal Cell Expression of Tlr9 is Required for Endogenous Donor-Reactive Memory Cd8 T Cell Activation within High-Risk Cardiac Allografts to Mediate Ctla-4 Ig Resistant Graft Rejection

    D. Ueda, H. Tsuda, S. Miyairi, R. L. Fairchild

  • Allograft Repopulating Recipient B Cells after Human Intestinal Transplantation and Their Association with Donor Specific Antibody Secretion and Rejection

    E. Waffarn1, J. Fu1, K. Frangaj1, W. Meng2, A. M. Rosenfeld2, M. Li3, K. Rodgers1, R. Vasilescu3, E. T. Luning Prak2, A. Griesemer1, T. Kato4, M. Martinez5, M. Sykes1

  • Allotransplantation of Ligated Arteriovenous Fistula as a Novel Strategy for Patients with Multiple Vascular Access Failures

    M. A. Jaramillo-Gante1, C. E. Acosta-Hernandez1, P. R. Castro-Casillas1, I. J. Linares-Cervantes2

  • Alterations in Left Ventricular Wall Thickness after Cardiac Transplantation

    C. K. Alvarez, O. Saeed, S. R. Patel, E. Borukhov, U. Jorde

  • Altering Homeostatic Repopulation with Thymic Irradiation and Donor Mesenchymal Stem Cell Infusions in a Nonhuman Primate Model

    R. Schmitz, M. S. Mulvihill, Z. W. Fitch, T. How, F. Leopardi, A. D. Kirk

  • Alternate Triazole Therapy for Breakthrough Invasive Fungal Disease in Lung Transplant Recipients on Triazole Prophylaxis

    A. Abbas, H. Hassouna, F. Marco Canosa, K. D. Brizendine

  • Altruistic Liver Donors at Thomas E Starzl Transplant Institute: Impact of the Educational Campaign: Gift of Life

    S. Ganesh, M. Molinari, L. Tubb, A. Tevar, C. Hughes, J. Behari, A. Humar

  • Alum Elicited MDSCs Delay the Rejection of Fully Mistmatched Islets in Mice

    A. Cuenca1, N. Feeney2, J. Ge1, K. Deng2, Q. Fu2, G. Huai2, K. Lee2, C. Rickert2, J. Markmann2

  • Ambient Air Pollution and Post-Transplant Mortality among US Kidney Transplant Recipients

    M. R. Jones1, Y. Feng2, N. Chu2, D. Segev2, M. McAdams-DeMarco1

  • Ambient Air Pollution and Waitlist Mortality among Lung Transplant Candidates

    Y. Feng1, M. R. Jones2, N. Chu1, D. Segev1, M. McAdams-DeMarco1

  • American Muslims & Informed Organ Donation Decisions: Findings from a Randomized, Controlled Trial of Religiously-Tailored Education in Mosques

    A. I. Padela1, R. Duivenbode2, M. Quinn1, M. Craig3, M. Saunders1

  • Amiodarone Use in Lung Transplant Recipients with New Onset Atrial Arrhythmias

    E. Klipsch1, R. Rachwan2, I. KutKut3, D. Roe2, C. Hage2, T. Hathaway1, R. S. Mangus2

  • An Early Look at the National Liver Review Board

    S. Noreen1, R. Hirose2, J. Trotter3, J. Heimbach4

  • An Evaluation of Converting Elderly Kidney Transplant Recipients from Tacrolimus to LCPT to Limit Neurological Adverse Events and Improve Quality of Life

    A. Reticker, B. Valdepenas, K. Bruno, D. Cikopana, S. Walton, E. Benedetti, I. Tzvetanov, P. West-Thielke

  • An Evaluation of Deceased Donor Eligibility and US Organ Donation Rates

    L. DeRoos1, Y. Zhou2, W. Marrero1, M. Lavieri1, D. Hutton3, N. Parikh4

  • An Immune-Modulatory Strategy to Mitigate Hepatic Ischemia Reperfusion/Injury in a Murine Model

    A. Kobayashi1, A. Wanchoo2, J. Simonovich2, S. Duarte1, V. Boominathan1, S. Shrestha1, G. Hudalla2, B. Keselowsky2

  • An OPO’s Experience in Increasing Transplantation with the Hope Project

    R. P. Wood, M. Ferguson, K. Myer, R. Cruz, P. Gillentine

  • An Optimized Integrative Model Using Urinary Chemokines for Noninvasive Diagnosis of Acute Allograft Rejection

    C. Tinel1, A. Devresse1, A. Vermorel1, D. Marx2, S. Caillard2, C. Legendre1, M. Rabant3, D. Anglicheau1

  • Analysis of 1000 Protocol Kidney Biopsies: Complications, Benefits, and Predictive Potential of Prior Sensitization

    M. Eslami1, J. Patel2, S. Karzai1, D. T. Collins1, C. Liu1, J. Jonsson1, R. Wali1, J. B. Piper1

  • Analysis of Factors Affecting Postoperative Hepatic Volume Increase in Liver Donor

    J. Cho, K. Lee, S. Hong, J. Lee, E. Han, K. Hong, N. Yi, K. Suh

  • Analysis of Pre-Transplant Resuscitation Factors Influencing Immediate Graft Function after Deceased Donor Kidney Transplantation

    S. Park

  • Analysis of Rejection, Rejection Therapy and Renal Function in the BEST Trial

    H. Kuzaro1, A. R. Shields2, A. Wiseman3, S. Tremblay1, A. Christianson1, D. Kaufman4, J. Leone5, A. Matas6, P. West-Thielke7, R. R. Alloway1, E. S. Woodle1

  • Analysis of the Mechanism of Liver-Resident NK Cells Activity via the Aryl Hydrocarbon Receptor

    K. Sato, M. Ohira, Y. Imaoka, H. Ohdan

  • Analysis of the Quality of Lung Transplantation in Mainland China During 2015- 2018

    H. Chun Xiao, L. Xiao Shan, C. Jing Yu

  • Analyzing Causes for Death-Censored Graft Failure

    M. Mayrdorfer, L. Liefeldt, N. Lachmann, W. Düttmann-Rehnolt, F. Halleck, M. G. Naik, P. Glander, K. Budde

  • Analyzing the Effect of a Closed Incision Negative Pressure Wound Therapy System on Wound Complications and Surgical Site Infections in Kidney Transplant Recipients: A Propensity Score Matched Analysis

    S. Lam, A. Huynh, J. M. Laurence

  • Anatomy of a Conversation: Assessing ESRD Patients’ Transplant-Related Communication

    H. M. Gardiner

  • ANG-3777 Treatment Attenuates Ischemia-Reperfusion-Induced Renal Injury in Rat and Dog Models

    P. Narayan1, M. Mangino2, I. D. Goldberg1

  • ANG-3777, A Hepatic Growth Factor Mimetic, Attenuates Mercuric Chloride-Induced Renal Dysfunction and Mortality in Rats

    P. Narayan, I. D. Goldberg

  • ANG-3777, A Hepatic Growth Factor Mimetic, Attenuates Post-Transplant Renal Dysfunction in Rats

    P. Narayan, I. D. Goldberg

  • Angiotensin II Type 1 Receptor Antibodies are Associated with Younger Age and Renal Dysfunction in Pediatric Kidney Transplantation

    M. Pearl1, E. T. Chambers2, A. Kirk2, R. Garro3, B. L. Warshaw3, P. Grimm4, R. Ettenger1, E. Reed1

  • Anonymous Living Donor Liver Donation: Establishing A Protocol and Understanding Donors Experience

    S. Shan1, J. Durden1, T. Seay2, P. Vargas3, S. Pelletier3, J. Oberholzer3, C. Argo4, N. Goldaracena3

  • Anti-CD321 Antibody (90G4) Protects Liver against Ischemia Reperfusion Injury in a Murine Model

    E. Yin1, T. Fukuhara2, H. Bashuda1, K. Uchida3

  • Anti-HLA IgM Antibodies are Unaffected by Imlifidase (IdeS) Treatment

    A. Runström1, R. Bockermann1, K. Sjöholm1, K. M. Roupé1, Å. Schiött1, L. Winstedt1, C. Kjellman1, T. Lorant2

  • Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Rejection – Molecular Rebound Phenomena Under IL-6 Blockade?

    A. Borski1, S. Haindl2, M. Duerr3, K. Budde3, S. Schranz1, F. A. Eskandary2, K. Doberer2, P. F. Halloran4, E. Chong5, B. Jilma1, G. A. Böhmig2, M. Wahrmann2

  • Anti-T Lymphocyte Immunoglobulins versus Basiliximab in Highly Sensitized Kidney-Transplant Patients without Preformed DSAs: The Satir Study

    N. Kamar1, L. Couzi2, L. Albano3, A. Durrbach4, V. Pernin5, L. Esposito1, M. Lequintrec5, P. Merville2, A. Del Bello1

  • Anti-Thymocyte Globulin Promotes Tfh Cells Differentiation and Alloantibody Production

    R. Benedetti Gassen, B. Aoyama, M. Lima, T. Borges, M. Pérez-Sáez, N. Murakami, P. Sage, J. Pascual, L. V. Riella

  • Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist and Deceased-Donor Kidney Transplant Outcomes among Older Recipients

    J. Ahn1, S. Bae1, K. Lentine2, M. Schnitzler2, G. Hess3, D. Segev1, M. McAdams-DeMarco1

  • Anti-Thymocyte Globulins Induced Immunomodulatory Effect and Increased Regulatory T Cell in a In Vitro Model of Allogeneic Cell Coculture

    M. Colladant1, J. Lion2, P. Saas3, S. Perruche3, D. Ducloux1, N. Mooney2, J. Bamoulid1

  • Antibiotic Pretreatment Alleviates Liver Transplant Damage by Modulating the Composition of Commensal Microbiota

    K. J. Dery, S. Kageyama, H. Hirao, K. Kadono, H. Kojima, R. W. Busuttil, J. W. Kupiec-Weglinski

  • Antibiotic Stewardship and Inpatient C. Difficile Testing in Solid Organ Transplant Recipients, the Value of Multi-Level Checks and Balances

    M. Kueht, R. Britt, R. Ferren, M. Mujtaba, R. Ramirez, R. Kulkarni, A. Lea, J. Fair, D. Reynoso

  • Antibodies to Vascular Autoantigens Are Associated with Poor Long-Term Survival of Liver Re-Transplant

    Q. Xu1, V. C. McAlister2, S. Leckie2, A. A. House2, A. Zeevi1

  • Antibody-Mediated Rejection with and without Donor-Specific Anti-HLA Antibodies: Performance of the Peripheral Blood 8-Gene Expression Assay

    E. Van Loon1, E. Lerut2, D. Anglicheau3, W. Gwinner4, M. Essig5, P. Marquet5, M. Naesens1

  • Antibody-Suppressor CD8+ T Cells Ameliorate Antibody-Mediated Rejection Following Kidney Transplant in Mice

    J. M. Zimmerer1, J. L. Han1, Q. Zeng2, B. A. Ringwald1, C. Cassol1, R. Warren1, M. Abdel-Rasoul1, C. K. Breuer2, G. L. Bumgardner1

  • Anticipated Cost Savings of Using Lungs from Hepatitis C-Positive Lung Donors for Hepatitis C-Negative Recipients

    K. Ryland1, J. Mallea2, J. Moriarty3, L. White4, B. Borah5, J. Naessens3

  • Anticipated Observations: The Role of DQ Antigen Frequencies among Donors and Recipients in a Pediatric Renal Transplant Cohort

    S. Gattis1, R. George2, R. Liverman3, A. Serluco3, R. Garro2, J. Figueroa2, R. A. Bray2, H. M. Gebel2, H. C. Sullivan2

  • Anticoagulation in Simultaneous Pancreas Kidney (SPK) Transplantation- On What Basis?

    J. Gopal, P. Herbert, J. Crane, F. Dor, V. Papalois, A. Muthusamy

  • Antimicrobial Prophylaxis Post Antibody Mediated Rejection Treatment in Pediatric Kidney Transplant Recipients: Interim Report from the Paramour “PediAtric Renal AMr Outcomes” Study

    S. Solomon1, R. Garro2, N. Hayde3, A. Jain4, M. Kallash5, K. Twombley6, I. Ashoor7

  • Apoptotic Exosome-Like Vesicles are Associated with Alloimmune Vascular Injury in Kidney Transplant Recipients

    M. Dieude1, E. Boilard2, I. Allaeys2, A. Deneault-Marchand1, J. Turgeon1, E. Dore2, S. Lariviere-Beaudoin1, A. Karakeussian-Rimbaud1, S. Collette3, L. Senecal3, M. Hebert1, H. Cardinal1

  • Application of Diffusional Kurtosis Imaging for Non-Invasive Assessment of Chronic Allograft Injury

    Y. Xu1, X. Zheng2, H. Liu1, X. Hu1

  • Application of Image-Guidance Using 2D Illustrations and 3D Modeling of Donor Anatomy During Living Donor Hepatectomy

    M. Lim, S. Kim, K. Kim, O. Lee, J. Kwon, E. Jeong, J. Yang, G. Choi

  • Are HLA-DQ De Novo Donor-Specific Antibodies a Risk Factor for Acute Humoral Rejection?

    R. Hod Dvorai1, C. A. Hubbell1, M. R. Laftavi2, R. Shahbazov2, B. Gallay3, O. G. Pankewycz3

  • Are Living Donor Offers a Missed Opportunity? A Social Network Analysis of End-Stage Renal Disease Patients

    A. Gillespie1, J. Cappiello2, R. L. Brown1, H. M. Gardiner2, E. L. Fink3, P. P. Reese4, C. Gadegbeku5, Z. Obradovic6

  • Are Molecular Diagnoses of Antibody Mediated Rejection (ABMR) Reliable in the Setting of Antibody-Antigen Complex Mediated Tissue Injury Unrelated to Alloimmunity?

    P. Randhawa1, Y. Huang1, G. Tseng2, K. Xiao3

  • Arterial Flow, Lactate and NGAL as a Decision Making Trinity in Normothermic Kidney Preservation

    A. Weissenbacher1, M. L. Lo Faro2, C. C. Coussios2, P. J. Friend2

  • Artificial Intelligence May Detect Donor Liver Steatosis and Predict Early Post-Transplantation Graft Failure

    R. R. Narayan, L. Yang, N. Abadilla, S. B. Chen, J. P. Higgins, M. L. Melcher

  • Artificial Intelligence May Predicts Early Sepsis in Liver Transplantation

    R. D. Kamaleswaran1, R. Lowell Davis2, J. D. Eason3, S. Sataphaty4, V. R. Mas5, D. Maluf3

  • Assessing Immunosuppression with Immunological Testing and Surveillance Biopsies Late after Liver and Intestine Transplantation (LT, IT)

    L. Remaley, R. Falik, K. Soltys, G. Bond, J. Winnier, P. Kachmar, C. Ashokkumar, A. Ganoza, A. Kepler, A. Khanna, J. Squires, P. McKiernan, J. Rudolph, F. Alissa, G. Mazariegos, R. Sindhi

  • Assessing Interventions to Improve Patient Care Conducted by Pharmacists at an Outpatient Renal Transplant Clinic within a Collaborative Pharmacy Practice Agreement

    K. Johnson, R. Chelewski, A. Langone, M. Peter, A. Zuckerman

  • Assessing Providers’ Accuracy in Predicting Early Readmission after Kidney and Liver Transplantation

    K. Maroney, Z. Wang, R. Lynch, A. Adams, R. Patzer, J. Hogan

  • Assessing the Complex Causes of Kidney Allograft Loss

    E. Van Loon1, A. Senev1, E. Lerut2, M. Coemans1, D. Kuypers1, M. Emonds1, M. Naesens1

  • Assessment of Coronary Allograft Vasculopathy by Intravascular Ultrasound 6 Weeks and One Year after Heart Transplantation: A Single Center Study

    A. Alam, E. Dib, H. Zafar, J. Felius, S. Hall, S. Joseph

  • Assessment of Deceased Donor Kidney and Liver Surgical Recovery Error Rates

    R. D. Hasz, S. M. West, H. M. Nathan

  • Assessment of HEALTh LIteracy on MEdication ADheREnce and Graft Outcomes in KIdney Transplant Recipients (Hallmark)

    M. Leung1, A. Dhanda2, S. Kwan3, A. Zienkiewicz3, E. Waters3, N. Wood3, L. Young3, C. Bannon3

  • Assessment of Infectious Complications Following ABO-Blood Group Incompatible Renal Transplant

    J. Banbury1, T. Loosier1, C. Lin2, K. Gutierrez1

  • Assessment of Rapid Optimized Flow Cytometric Crossmatch (FCXM) Assay with Luminex Class I Single Antibody Test

    J. Yoo1, S. Lee2, J. Jang3, A. Choi2, E. Oh1

  • Assessment of Sarcopenia and Obesity by Bioelectrical Impedance Analysis in Transplant and Hepatobiliary Populations

    J. Konel1, T. Kitajima2, L. Arevalo1, N. Murray1, T. Pietrowsky2, D. Venkat2, H. Gonzalez2, M. Samaniego2, M. Abouljoud2, S. Nagai2

  • Assessment of the Usefulness of Urine Signature to Differentiate Acute Rejection in a Prospective Kidney Transplantation Cohort

    J. Seo1, S. Jung2, J. Moon2, K. Jeong3, C. Kim4, B. Chung5, J. Park6, Y. Kim7, S. Lee2

  • Assessment of Time to Therapeutic Tacrolimus Levels Following Renal Transplantation in a Non-Weight-Based Dosing Model

    J. Banbury1, A. Dodson1, C. Lin2, K. Gutierrez1

  • Association between Alcoholic Liver Disease and Alcohol Tax

    S. Melo1, A. Ermekbaeva2, J. Buggs3, E. Rogers3, A. Kumar4, N. Kemmer5

  • Association between Area-Level Measures of Deprivation and Readiness to Pursue Living Donor Kidney Transplant

    M. A. Saqib, A. Li, J. Hussain, Q. Wang, N. El-Dassouki, A. Dychiao, L. Angarso, N. Edwards, M. Novak, I. Mucsi

  • Association between Education and Waitlist Mortality, Access to Transplant, and Post-Transplant Survival among Patients with Alcohol-Associated Liver Disease

    A. T. Strauss, J. Motter, D. Segev, A. Massie, T. Purnell, J. Hamilton, A. Gurakar, A. Cameron, J. Garonzik-Wang

  • Association between Ezetimibe Usage and Hepatitis C RNA Levels in Uninfected Kidney Transplant Recipients Who Received Hepatitis C Infected Kidneys

    A. Azhar, M. Yazawa, M. Talwar, V. Balaraman, A. Bhalla, U. A. Agbim, B. Maliakkal, J. P. Kothadia, S. Nair, J. D. Eason, M. Z. Molnar

  • Association between Homograft Tissue Exposure and Pre-Sensitization Prior to Heart Transplant in Patients with Congenital Heart Disease

    D. J. Donovan1, M. E. Richmond2, E. A. Bacha3, L. J. Addonizio2, W. A. Zuckerman2

  • Association between Longer Hospitalization and Development of De Novo Donor Specific Antibody in Simultaneous Liver­-Kidney Transplant Recipients

    M. Yazawa1, O. Cseprekal2, R. A. Helmick1, M. Talwar1, V. Balaraman1, P. S. Podila3, S. Fossey4, S. K. Satapathy5, J. D. Eason1, M. Z. Molnar1

  • Association between Mycoplasma and Ureaplasma Airway Colonization, Ammonia Levels and Outcomes Post Lung Transplantation

    B. Buzo1, J. Preiksaitis1, K. Halloran2, J. Nagendran3, D. Townsend4, N. Zelyas5, W. Sligl4

  • Association between Pre-Transplant Frailty and Increased Length of Stay after Lung Transplantation

    J. Schaenman, N. Ventigan, J. Huang, S. Jaladanki, L. Shih, S. Gee, D. Sayah, S. S. Weigt, A. Ardehali, R. Biniwale, D. Goldwater

  • Association between Response to Rituximab and Risk of Antibody-Mediated Rejection in ABO-Incompatible Living Kidney Transplantation

    Y. Kakuta1, M. Okumi1, T. Kanzawa1, K. Unagami2, H. Ishida2, K. Tanabe1

  • Association between Sarcopenia and Nutritional Factors in Kidney Transplant Recipients

    A. Kosoku1, J. Uchida1, T. Ishihara2, T. Iwai1, H. Shimada1, K. Kabei1, S. Nishide1, T. Naganuma1, T. Nakatani1

  • Association of Congenital Anomalies of the Kidney and Urinary Tract with Urinary Tract Infection and Graft Rejection in Pediatric Kidney Transplant Recipients

    M. Bock, D. Han, A. Sikora, K. Mckinnon, S. Hecht, M. Chandran, V. Vemulakonda

  • Association of Discharge Immunosuppressive Regimen with Treated Acute Rejection and Bronchiolitis Obliterans Syndrome in Adult Lung Transplantation: An Analysis of Organ Procurement and Transplantation Network Data

    W. S. Cherikh1, B. J. Plucinski1, S. Palmer2, W. E. Fitzsimmons3

  • Association of Kidney Allograft Fibrosis-Associated Proteins with Chronic Lung Allograft Dysfunction

    S. Farkona1, G. Berra2, Z. Mohammed-Ali1, P. Ly2, L. Levy2, B. Renaud-Picard2, G. Zehong2, T. Daigneault2, S. Juvet2, C. McEvoy1, S. Clotet-Freixas1, T. Martinu2, A. Konvalinka1

  • Association of Perfusion Characteristics and Post-Transplant Liver Function in Ischemia-Free Liver Transplantation

    Z. Zhang, Y. Tang, Q. Zhao, Z. Guo, X. He

  • Association with Acute Kidney Injury and Chronic Kidney Disease after Liver Transplantation

    R. Ide, M. Ohira, H. Ohdan

  • Associations of Chronic Kidney Disease with Temperature, Ancestry and Employment

    A. A. Connor, B. I. Shaw, K. V. Ravindra

  • ATHENA – Patient and Allograft Outcome Differences after Kidney Transplantation – Germany vs. France

    F. Thaiss1, C. Sommerer1, B. Suwelack1, D. Dragun1, I. A. Hauser1, O. Witzke1, C. Hugo1, P. Schenker1, N. Kamar2, P. Merville2, I. Kroeger3, M. Junge3, B. Nashan1

  • Atrial Fibrillation Predicts Inferior Survival in Liver Transplant Recipients of Advanced Age in a Large Multicenter U.S. Cohort

    M. German1, A. Hristov1, A. Lee1, F. Osman1, A. Kwong2, D. Devuni3, C. Wang4, J. Boike5, J. Jo5, L. VanWagner5, M. Serper6, R. Sharma7, E. Verna7, J. Shor3, A. Koteish8, G. Sehmbey9, A. Seetharam9, N. John2, Y. Patel10, M. Kappus10, T. Couri11, S. Paul11, R. Salgia12, Q. Nhu13, C. Frenette13, J. Lai4, A. Goel2, E. Spengler1

  • Attempted Validation of Lims1 Variant Rs893403 with Acute Rejection Risk

    W. S. Oetting1, G. Weihua1, C. R. Dorr1, R. B. Mannon2, A. J. Matas1, P. A. Jacobson1, A. K. Israni1

  • Attitudes Toward Organ, Tissue, and Vascularized Composite Allograft Donation and Transplantation: A Survey of United States Military Veterans

    J. R. Rodrigue1, S. Ward1, M. Boger2, A. Fleishman1, J. Shenkel1, A. Calvo1, R. Zwolak3, N. Krishnan4, B. Pomahac5

  • Autoimmune Responses to DNA Topoisomerase I Exacerbate Renal Allograft Injury

    V. Gorbacheva, R. Fan, S. Miyairi, W. Baldwin, R. Fairchild, A. Valujskikh

  • Autologous Expanded Tregs Promote Bone Marrow Engraftment and Donor Kidney Survival in Non-Human Primate Chimerism Model

    K. Bruestle1, P. Alonso-Guallart1, H. Sakai1, F. Fredriksson1, B. Piegari1, E. Lopes1, G. Pierre1, A. Shou1, D. Ekanayake-Alper1, J. Weiner1, A. Iuga2, S. M. Coley2, M. Sykes1, A. Griesemer1

  • Automated Electronic Donor Referrals Have Increased Donation

    J. Piano

  • Automated Monitoring of Four Urinary Biomarkers in Routine Surveillance Identifies Patients at Low and High Risk of Renal Allograft Injury

    L. Sheward1, J. Wedel1, N. Rodig1, R. Mannon2, O. Bestard3, V. Dharnidharka4, D. Zurakowski1, A. Kho1, T. Blydt-Hansen5, M. Seifert2, D. M. Briscoe1

  • Automatic Quantification of Interstitial Fibrosis in Renal Allograft

    J. Hogan1, J. Vizcarra2, M. A. Tageldin2, L. A. Cooper3, D. A. Gutman2, A. B. Farris4

  • Autophagy Attenuates Renal Allograft Interstitial Fibrosis by Regulating the EndMT Induced by TNF-α

    Z. Gui, C. Suo, Z. Wang, S. Fei, Z. Han, J. Tao, H. Chen, L. Sun, X. Ju, R. Tan, M. Gu

  • Autophagy-Lysosome Inhibitor Chloroquine Prevents CTLA-4 Degradation of T Cells and Attenuates Acute Rejection in Murine Skin and Heart Transplantation

    J. Wu

  • Avoiding Surveillance Biopsy: How? When? Now!

    A. Ang1, C. Schieve2, S. Rose2, C. Kew1, M. R. First2, R. B. Mannon1

Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences